Keyphrases
Respiratory Syncytial Virus
100%
Human Respiratory Syncytial Virus (hRSV)
100%
Mycobacterium Bovis
100%
Heme oxygenase-1 (HO-1)
100%
Nucleoprotein
27%
Bacillus Calmette-Guérin
27%
Epithelial Cells
18%
Lung
18%
Post-infection
18%
Immunization
18%
Alveolar Macrophages
18%
BCG Strain
18%
Recombinant BCG
18%
Immune Response
9%
Quantitative PCR
9%
Dendritic Cells
9%
Age of Infection
9%
Neutrophils
9%
Flow Cytometry
9%
Immunopathology
9%
Reinfection
9%
Recombinant
9%
Viral Infection
9%
Host Immune Response
9%
Infected Mice
9%
Infiltration
9%
Recombinant Vaccine
9%
Infection Model
9%
Immune Cells
9%
Immunization Programs
9%
Immune Surveillance
9%
Lung Pathology
9%
Long-lasting Effect
9%
Differential Expression Pattern
9%
Innate Immune Cells
9%
Secondary Infection
9%
High Induction
9%
Macrophage Recruitment
9%
Primary Infection
9%
Attenuated Strain
9%
Protective Immunity
9%
Mycobacterium
9%
Interstitial Macrophages
9%
Surveillance System
9%
Pulmonary Tissue
9%
Recurrent Epidemics
9%
Pulmonary Immune Response
9%
Primary Pathogen
9%
Conditioning Factors
9%
Critical Genes
9%
Lung Epithelium
9%
Severe Lower Respiratory Tract Infections
9%
Immunomodulatory Molecules
9%
Lymphocyte Dynamics
9%
Adult Humans
9%
Late Infection
9%
Opportunistic Infections
9%
Immunology and Microbiology
Human Respiratory Syncytial Virus
100%
Mycobacterium bovis
100%
Heme
100%
Mycobacterium Bovis BCG
50%
Nucleoprotein
30%
Immune Response
20%
Mouse
20%
Alveolar Macrophage
20%
Dendritic Cell
10%
Dynamics
10%
Infectious Agent
10%
Quantitative Reverse Transcription Polymerase Chain Reaction
10%
Immunopathology
10%
Leukocyte
10%
Immunosurveillance
10%
Neutrophil Granulocyte
10%
Vaccine Efficacy
10%
Lower Respiratory Tract
10%
Host Immune Response
10%
Immunocompetent Cell
10%
Viral Disease
10%
Conditioning
10%
Synthetic Vaccine
10%
Mycobacteria
10%
Opportunistic Infection
10%
Lung Epithelium
10%